These findings reveal that PI3K/AKT‐driven metabolic reprogramming, specifically via HIF‐1α upregulation, contributes significantly to 5‐FU resistance in CRC, highlighting the need for strategies targeting glucose metabolism. The gene discussed is PIK3CA; the disease is colorectal carcinoma.